908 Devices Yönetim
Yönetim kriter kontrolleri 3/4
908 Devices CEO'su Kevin Knopp, Feb2012 tarihinde atandı, in görev süresi 14.58 yıldır. in toplam yıllık tazminatı $ 1.55M olup, şirket hissesi ve opsiyonları dahil olmak üzere 32.2% maaş ve 67.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 2.65% ine doğrudan sahiptir ve bu hisseler $ 11.58M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 0.8 yıl ve 5.6 yıldır.
Anahtar bilgiler
Kevin Knopp
İcra Kurulu Başkanı
US$1.6m
Toplam tazminat
| CEO maaş yüzdesi | 32.19% |
| CEO görev süresi | 14.6yrs |
| CEO sahipliği | 2.7% |
| Yönetim ortalama görev süresi | less than a year |
| Yönetim Kurulu ortalama görev süresi | 5.6yrs |
Son yönetim güncellemeleri
Recent updates
Anlatı Güncellemesi • Sep 09
MASS: Higher 2026 Revenue Outlook Will Support A Stronger Share Price
Analysts have raised the 908 Devices fair value estimate from $11 to $13, citing updated assumptions on the discount rate, revenue growth, profit margin, and future P/E that shift their overall price target framework. What’s in the News for 908 Devices 908 Devices updated full year 2026 earnings guidance, setting a revenue range of $68.0 million to $70.0 million and lifting the lower end from $67.0 million.
Anlatı Güncellemesi • Aug 26
MASS: Raised 2026 Outlook And Index Removals Will Shape Future P/E
Analysts have raised their fair value estimate for 908 Devices from $10 to $12, citing updates to key assumptions, including the discount rate, revenue growth outlook, profit margin profile, and future P/E expectations. What’s in the News for 908 Devices 908 Devices updated its full year 2026 revenue guidance to a range of $68.0 million to $70.0 million, compared with the previous range of $67.0 million to $70.0 million.Seeking Alpha • Aug 12
908 Devices: Mission Critical Devices Drive Growth
Summary 908 Devices is rated BUY after a 2Q26 earnings beat, strong revenue growth, and a 97% YTD share price gain. MASS benefits from robust demand for chemical detection devices, driven by law enforcement, defense, and volatile geopolitical conditions. Recurring revenue from NIRLab and product upgrades like VipIR underpin stable growth; management raised FY26 revenue guidance to $68–$70M. Valuation remains reasonable at 5.5x forward P/S, supported by a $101.5M cash position, no debt, and narrowing EBITDA losses. Read the full article on Seeking Alpha
Anlatı Güncellemesi • Aug 12
MASS: Index Removals Will Set Up A Future Repricing Opportunity
Analysts have updated their fair value estimate for 908 Devices from $12.00 to $14.00, reflecting revised assumptions around revenue growth, profit margins, discount rates, and future P/E expectations. What’s in the News for 908 Devices 908 Devices was dropped from the Russell 2500 Growth Benchmark, according to index classification data.Anlatı Güncellemesi • Jun 18
MASS: Raised 2026 Revenue Outlook Will Support A Higher Stock Price
Analysts have lifted their price target on 908 Devices stock from $10.00 to $11.00, citing updated assumptions around fair value, revenue growth, discount rate and future P/E that they consider better aligned with the company's current outlook. What’s in the News for 908 Devices 908 Devices raised its full year 2026 revenue guidance, according to a key developments summary.Anlatı Güncellemesi • Jun 03
MASS: Raised 2026 Revenue Outlook Will Support Higher Future P/E Multiple
Analysts have modestly adjusted their price targets on 908 Devices, reflecting updated assumptions for a fair value of $10.00, a slightly higher discount rate, marginally stronger projected revenue growth, a softer profit margin outlook, and a higher future P/E of about 70x. What's in the News 908 Devices raised its full year 2026 revenue guidance to a range of $67.0 million to $70.0 million.Anlatı Güncellemesi • May 12
MASS: Raised 2026 Revenue Guidance Will Support Higher Earnings Multiple
Analysts have reset their price target on 908 Devices to $10.00 from $8.00, citing updated assumptions around revenue growth, profitability, and future P/E that feed into a higher fair value estimate and a modestly higher discount rate. What's in the News 908 Devices raised full year 2026 revenue guidance to a range of $67.0 million to $70.0 million, compared with 2025 revenue, with the range described as representing 19% to 25% growth (Corporate Guidance: Raised).Analiz Makalesi • Jan 23
908 Devices Inc.'s (NASDAQ:MASS) 29% Price Boost Is Out Of Tune With Revenues
Those holding 908 Devices Inc. ( NASDAQ:MASS ) shares would be relieved that the share price has rebounded 29% in the...Analiz Makalesi • Nov 12
Some 908 Devices Inc. (NASDAQ:MASS) Shareholders Look For Exit As Shares Take 26% Pounding
908 Devices Inc. ( NASDAQ:MASS ) shareholders won't be pleased to see that the share price has had a very rough month...Analiz Makalesi • Sep 20
908 Devices Inc.'s (NASDAQ:MASS) Share Price Not Quite Adding Up
When close to half the companies in the Electronic industry in the United States have price-to-sales ratios (or "P/S...Analiz Makalesi • Aug 07
908 Devices Inc. (NASDAQ:MASS) Analysts Are Pretty Bullish On The Stock After Recent Results
NasdaqGM:MASS 1 Year Share Price vs Fair Value Explore 908 Devices's Fair Values from the Community and select yours...Anlatı Güncellemesi • Aug 06
US Federal And International Funding Will Expand Global Analysis Markets
The notable increase in 908 Devices’ price target reflects improved outlook due to higher expected revenue growth and an expanded forward P/E, raising the consensus fair value from $6.50 to $9.00. What's in the News 908 Devices raised its 2025 revenue guidance to $54–56 million (13–17% growth), up from prior guidance of $53–55 million.Analiz Makalesi • Jun 11
908 Devices Inc.'s (NASDAQ:MASS) Shares Climb 26% But Its Business Is Yet to Catch Up
Despite an already strong run, 908 Devices Inc. ( NASDAQ:MASS ) shares have been powering on, with a gain of 26% in the...
Yeni Anlatı • Apr 06
The New Handheld Mass Spectrometer Launch Will Expand Market Reach
Divesting the desktop bioprocessing portfolio boosts cash reserves, streamlines operations, and is expected to enhance margins and cash flow in future years.Seeking Alpha • Mar 06
908 Devices Makes Key Divestiture (Rating Upgrade)
Summary 908 Devices' stock surged after announcing a $70 million desktop portfolio sale, doubling its cash position and improving financial stability. The company will now focus on its handheld device business, expecting 11% to 15% revenue growth in 2025 with acceleration in 2026. MASS management believes losses will be significantly reduced with the new structure, with positive cash flow next year. Read the full article on Seeking AlphaAnaliz Makalesi • Mar 05
908 Devices Inc.'s (NASDAQ:MASS) 55% Jump Shows Its Popularity With Investors
The 908 Devices Inc. ( NASDAQ:MASS ) share price has done very well over the last month, posting an excellent gain of...Analiz Makalesi • Nov 15
Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts
The analysts might have been a bit too bullish on 908 Devices Inc. ( NASDAQ:MASS ), given that the company fell short...Seeking Alpha • Sep 08
908 Devices: Key Investor Now Selling
Summary ARK Invest's recent sales of 908 Devices shares have helped to send the stock to multi-year lows. 908 Devices is seeing decent revenue growth, but large losses and limited financial flexibility raise concerns about future capital needs. The stock's low valuation compared to peers is a positive, but ongoing sales by ARK Invest could exert further downward pressure. Read the full article on Seeking AlphaAnaliz Makalesi • Aug 16
Why We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge
To the annoyance of some shareholders, 908 Devices Inc. ( NASDAQ:MASS ) shares are down a considerable 29% in the last...Analiz Makalesi • Mar 30
We Think 908 Devices (NASDAQ:MASS) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...Analiz Makalesi • Dec 18
Investors Appear Satisfied With 908 Devices Inc.'s (NASDAQ:MASS) Prospects
When you see that almost half of the companies in the Electronic industry in the United States have price-to-sales...CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2026 | n/a | n/a | -US$34m |
| Mar 31 2026 | n/a | n/a | -US$35m |
| Dec 31 2025 | US$2m | US$500k | -US$33m |
| Sep 30 2025 | n/a | n/a | -US$73m |
| Jun 30 2025 | n/a | n/a | -US$62m |
| Mar 31 2025 | n/a | n/a | -US$57m |
| Dec 31 2024 | US$2m | US$498k | -US$53m |
| Sep 30 2024 | n/a | n/a | -US$45m |
| Jun 30 2024 | n/a | n/a | -US$28m |
| Mar 31 2024 | n/a | n/a | -US$30m |
| Dec 31 2023 | US$1m | US$475k | -US$36m |
| Sep 30 2023 | n/a | n/a | -US$39m |
| Jun 30 2023 | n/a | n/a | -US$38m |
| Mar 31 2023 | n/a | n/a | -US$37m |
| Dec 31 2022 | US$2m | US$477k | -US$34m |
| Sep 30 2022 | n/a | n/a | -US$27m |
| Jun 30 2022 | n/a | n/a | -US$26m |
| Mar 31 2022 | n/a | n/a | -US$25m |
| Dec 31 2021 | US$760k | US$400k | -US$22m |
| Sep 30 2021 | n/a | n/a | -US$29m |
| Jun 30 2021 | n/a | n/a | -US$26m |
| Mar 31 2021 | n/a | n/a | -US$18m |
| Dec 31 2020 | US$591k | US$284k | -US$13m |
| Sep 30 2020 | n/a | n/a | -US$3m |
| Jun 30 2020 | n/a | n/a | -US$6m |
| Mar 31 2020 | n/a | n/a | -US$11m |
| Dec 31 2019 | US$445k | US$287k | -US$13m |
Tazminat ve Piyasa: Kevin 'nin toplam tazminatı ($USD 1.55M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 2.41M ).
Tazminat ve Kazançlar: Kevin 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Kevin Knopp (53 yo)
14.6yrs
Görev süresi
US$1,553,502
Tazminat
Dr. Kevin J. Knopp, Ph D., Co-Founded 908 Devices Inc. in 2012 and serves as its Chief Executive Officer, President and Director since February 2012. Dr. Knopp Co-Founded Ahura Scientific, Inc. in 2002 and...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder | 14.6yrs | US$1.55m | 2.65% $ 11.6m | |
| Co-Founder | 14.7yrs | Veri yok | 1.88% $ 8.2m | |
| CFO & Treasurer | 12.5yrs | US$1.14m | 0.29% $ 1.3m | |
| Chief Legal | less than a year | US$1.65m | Veri yok | |
| Senior Vice President of Sales and Product Marketing | no data | US$1.03m | 0.14% $ 609.6k | |
| Global Head of Human Resources | less than a year | Veri yok | Veri yok | |
| Senior Vice President of Products and Production | less than a year | Veri yok | 0.11% $ 474.0k | |
| Chief Business & Strategy Officer | less than a year | Veri yok | Veri yok |
0.8yrs
Ortalama Görev Süresi
53yo
Ortalama Yaş
Deneyimli Yönetim: MASS 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 0.8 yıl), bu da yeni bir ekibin varlığını gösteriyor.
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder | 14.6yrs | US$1.55m | 2.65% $ 11.6m | |
| Co-Founder | 1.5yrs | Veri yok | 1.88% $ 8.2m | |
| Independent Director | 14.3yrs | US$202.51k | 0.095% $ 415.4k | |
| Independent Director | 5.6yrs | US$200.43k | 0.099% $ 431.4k | |
| Independent Chairman of the Board | 13yrs | US$222.51k | 1.2% $ 5.2m | |
| Independent Director | 14.3yrs | US$200.01k | 0.22% $ 942.6k | |
| Independent Director | 4.5yrs | US$183.34k | 0.11% $ 466.0k | |
| Independent Director | 2.3yrs | US$175.01k | 0.065% $ 285.4k | |
| Independent Director | 1.1yrs | US$216.63k | 0.013% $ 54.8k |
5.6yrs
Ortalama Görev Süresi
62yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: MASS 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.6 yıldır).
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/09/19 04:46 |
| Gün Sonu Hisse Fiyatı | 2026/09/18 00:00 |
| Kazançlar | 2026/06/30 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
908 Devices Inc. 6 Bu analistlerden 6, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Austin Moeller | Canaccord Genuity |
| Puneet Souda | Leerink Partners LLC |
| Max Masucci | Roth Capital Partners |